These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 5260431)

  • 1. [Effects of the combined antileukemic therapy with various agents on the ultrastructure of the bone marrow cells of patients with myelogeous leukemia].
    Nagao T; Sakamoto T; Saito K; Kitajima K
    Igaku To Seibutsugaku; 1969 Oct; 79(4):167-9. PubMed ID: 5260431
    [No Abstract]   [Full Text] [Related]  

  • 2. Timed sequential therapy of human leukemia based upon the response of leukemic cells to humoral growth factors.
    Burke PJ; Karp JE; Braine HG; Vaughan WP
    Cancer Res; 1977 Jul; 37(7 Pt 1):2138-46. PubMed ID: 266416
    [No Abstract]   [Full Text] [Related]  

  • 3. [How to be an administration schedule of antileukemic agents in the treatment of acute leukemia from the standpoint of leukemic cell kinetics (author's transl)].
    Shirakawa S
    Nihon Ketsueki Gakkai Zasshi; 1974 Oct; 37(5):707-30. PubMed ID: 4533927
    [No Abstract]   [Full Text] [Related]  

  • 4. [The "cytological dysplasia" caused by antimitotics].
    Castoldi GL; Scapoli GL
    Arch Ital Patol Clin Tumori; 1966; 9(1):3-42. PubMed ID: 5241698
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of myelocytic leukemia during blast transformation (preliminary report)].
    Frinovskaia IV; Bogomolova LV
    Sov Med; 1976 Aug; (8):28-32. PubMed ID: 1070163
    [No Abstract]   [Full Text] [Related]  

  • 6. Diffusion chamber cultures of bone marrow cells in refractory anemia with excess oil blasts (RAEB).
    Izzi T; Fontebuoni A; Talevi N; Lucarelli G
    Haematologica; 1981 Oct; 66(5):570-8. PubMed ID: 6796466
    [No Abstract]   [Full Text] [Related]  

  • 7. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
    Betticher DC; Huxol H; Müller R; Speck B; Nissen C
    Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors.
    Feuring-Buske M; Frankel AE; Alexander RL; Gerhard B; Hogge DE
    Cancer Res; 2002 Mar; 62(6):1730-6. PubMed ID: 11912147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On the consolidation, maintenance and reconsolidation treatment of acute leukemia (author's transl)].
    Masaoka T
    Nihon Ketsueki Gakkai Zasshi; 1974 Oct; 37(5):748-55. PubMed ID: 4533929
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
    Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
    Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy of acute leukemia.
    Holland JF
    Hamatol Bluttransfus; 1970; 9():58-65. PubMed ID: 5279393
    [No Abstract]   [Full Text] [Related]  

  • 12. The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement.
    Castagnola C; Nozza A; Corso A; Bernasconi C
    Haematologica; 1997; 82(5):577-80. PubMed ID: 9407724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
    Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
    Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Problems in the treatment of stem cell leukemias in aged patients].
    Trux F; Fink R; Wutke K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(4):516-22. PubMed ID: 64389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation of patients with high risk acute myeloid leukemia in first remission with autologous marrow cultured in interleukin-2 followed by interleukin-2 administration.
    Klingemann HG; Eaves CJ; Barnett MJ; Eaves AC; Hogge DE; Nantel SH; Reece E; Shepherd JD; Sutherland HJ; Phillips GL
    Bone Marrow Transplant; 1994 Sep; 14(3):389-96. PubMed ID: 7994260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-azacytidine in childhood leukemia.
    Hrodek O; Veselý J
    Neoplasma; 1971; 18(5):493-503. PubMed ID: 5287028
    [No Abstract]   [Full Text] [Related]  

  • 17. [Carminomycin in the therapy of leukemias].
    Vygovskaia IaI; Mazurok AA; Kondrat'eva NA; Orel VG
    Antibiotiki; 1982 Aug; 27(8):632-5. PubMed ID: 6957161
    [No Abstract]   [Full Text] [Related]  

  • 18. [Indirubin in the treatment of chronic myelocytic leukemia (CML)--estimation of labelling index of bone marrow cells by 3H-TdR].
    You YC; Mi JX; Wan JH; Yang TY; Wang ZC; Qian LS
    Zhonghua Zhong Liu Za Zhi; 1987 Nov; 9(6):418-20. PubMed ID: 3482992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of chemotherapy on mortality in acute leukemia].
    Yamda K; Imai K; Koie K; Kamiya T; Nishiwaki H
    Nihon Rinsho; 1975 May; 33(5):1811-7. PubMed ID: 1057031
    [No Abstract]   [Full Text] [Related]  

  • 20. Cumulative chemotherapy increases mafosfamide toxicity for normal progenitor cells in AML patients: rationale for cryopreserving adapted-dose purged marrow early in first complete remission.
    Martin H; Bruecher J; Claudé R; Hoelzer D
    Bone Marrow Transplant; 1993 Nov; 12(5):495-9. PubMed ID: 8298560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.